Central Broadcasting Network Shanghai February 17 news (reporter Yang Jing Lin Fuyu) malignant tumors have become one of the high incidence of diseases in China, all kinds of new anti-tumor drugs can greatly extend the survival time of tumor patients, but also bring about heart toxic side effects that cannot be ignored. At the same time, with the increase in the life expectancy of tumor patients, the probability of concomitant cardiovascular diseases also increases, and how to formulate a treatment plan for this population has become a new test of current tumor treatment.
On February 17, Ge Junbo, academician of the Chinese Academy of Sciences and director of the Department of Cardiology of Zhongshan Hospital affiliated to Fudan University, Ma Xingfa, secretary of the Party Group of the Shanghai Association of Science and Technology, Wang Tong, director of the Health Promotion Department of the Shanghai Municipal Health Commission, and patient representatives gathered in the "Science and Technology Hall" of the Shanghai Science Hall to talk about "oncology cardiology" and share the latest research results in the field.
Medical, scientific and technological, science and technology celebrities as guests of the "science and technology living room" (central broadcasting network issued by the interviewee to provide a picture)
"Got a tumor, but died of the heart"?!
"Got a tumor, but died of the heart" seems to be contrary to daily cognition, but it really happens to many patients with malignant tumors, based on the actual demands of patients, a new interdisciplinary discipline - tumor cardiology has emerged.
Under the leadership of Ge Junbo and Cheng Leilei, director of fudan Zhongshan Cardiology sub-specialty, Zhongshan Hospital took the lead in opening the first multidisciplinary joint outpatient clinic of oncology cardiology in East China in April 2018, and in May 2021, it took the lead in opening a special outpatient clinic for oncology and cardiology, which opened a new window for tumor patients with cardiovascular disease. In the past four years, Fudan Zhongshan Oncology Cardiology team has provided cutting-edge medical guidance to thousands of patients with tumors and cardiovascular diseases.
In order to let this emerging discipline enter the public eye, the team rewrote the real clinical cases into medical science storybooks, filmed micro-films, and used various forms of popular science to "run to tell each other", hoping that medical staff and patients can discover this field and work together to improve the quality of life of tumor patients.
Ge Junbo stressed that science popularization can not only prevent the occurrence of diseases, but also play an important role in improving the prognosis of patients. Ma Xingfa pointed out that in order to realize the strategy of strengthening the country through science and technology, it is necessary to promote the development of scientific innovation and scientific popularization. At the same time, he affirmed the outstanding contributions made by the tumor cardiology team of Zhongshan Hospital in the science popularization work, and advocated medical experts, entrepreneurs, scientific and technological workers and media friends to work together to promote the science popularization work to a new level. Wang Tong pointed out that young doctors should be the new force, backbone and backbone force of the spread of cancer and heart disease science, hoping that medical institutions at all levels and the majority of medical workers will give full play to their advantages, strengthen doctor-patient communication and science popularization, and accurately match the health needs of the people. Hu Bingfu stressed that science and technology is the first driving force for development, and science popularization is the foundation for promoting the development of science and technology. Other guests explained their understanding and views on science communication from the perspectives of doctors, patients and pharmaceutical companies.
Promote the "dialogue" between cardiovascular and tumors, and "Say Something in your Heart 3" was released
As the leader of the "Oncology Cardiology" team of Zhongshan Hospital, Cheng Leilei has been deeply involved in medical science popularization, and her cardiovascular science story books such as "Doctors Know Your Heart Best", "Speak from the Heart" and "Say a Heart 2" have achieved good response among patients. "Speak from the Heart 3" was released at this event and published by the People's Medical Publishing House. The book will be obscure medical knowledge points, with plain language, delicate brushstrokes into the human condition, explain how to early judgment of cardiovascular diseases, early prevention, scientific medical treatment. The story is selected from more than 10,000 cases handled in the past 20 years of clinical practice, and especially focuses on the general knowledge of tumor cardiology that is little known to the public, such as how to conduct cardiac self-monitoring when patients with malignant tumors are treated with immune checkpoint inhibitors, and how to seek medical treatment once breast cancer patients have heart problems. The guests and Du Xian, editor-in-chief of the People's Medical Publishing House, carried out online and offline interaction around the new book.
Led by Cheng Leilei, Fudan Zhongshan's "Speak from the Heart" cardiovascular science popularization all-media matrix promotion team is the "science popularization communication special team" of Shanghai Science and Technology Association.
Compiled 2 clinical reference books to promote the development of oncology and cardiology in China
In order to better promote the development of oncology cardiology in mainland China, fudan Zhongshan oncology cardiology team gathered experience, sorted out processes, and absorbed the strengths of all to compile the "Concise Clinical Guidance Manual for Oncology Cardiology", which is the first practical summary of the field of oncology cardiology in mainland China, "As an emerging interdisciplinary discipline, tumor cardiology needs more academic books with clinical practical guidance value. Ge Junbo said.
It is reported that the Fudan Zhongshan Tumor Cardiology Team has struck again, and "Real-World Case of Tumor Cardiology Suo Ji" has been compiled and will be published and distributed soon. Ge Junbo and Wang Weidong, editor-in-chief of Fudan Publishing House, also shared on how to create these two dry academic books.